VAERS reports by lot

Merck Pneumococcal lot U026796: VAERS reports

48 VAERS reports list lot U026796 as a Merck Pneumococcal vaccine, received between 2022-03-11 and 2023-11-15. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
48
Reports
0%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2933%
General / Systemic (non-local)1618%
Musculoskeletal1214%
Cardiac / Cardiovascular78%
Gastrointestinal78%
Neurological56%
Dermatological (non-injection-site)56%
Allergic / Anaphylactic45%
Respiratory11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California10
Michigan6
Indiana4
Pennsylvania3
Wisconsin3
Colorado3
Connecticut2
New Jersey2
Iowa2
Arkansas2
Minnesota2
Washington1

Reports by month received

2022-034
2022-047
2022-055
2022-065
2022-072
2022-083
2022-091
2022-102
2022-112
2023-012
2023-029
2023-031
2023-042
2023-052
2023-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.